In patients with moderate dysglycemia or early type 2 diabetes, hemoglobin A1c (A1C) and fasting plasma glucose (FPG) levels are strongly related, and this relationship is impacted by oral therapies but not affected by geographic region or patient ethnicity.
Sign in with your MPR account
Keep me signed in Forgot your password?
REGISTER FOR FREE WITH A MPR ACCOUNT
Enter your MPR registration email address to receive a new password.